½ÃÀ庸°í¼­
»óǰÄÚµå
1726317

½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ - Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Duodenoscopes Market Size, Share & Trends Analysis Report By Product (Reusable, Disposable), By Application (Diagnostics, Therapeutics/Treatment), By End Use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå ±Ô¸ð ¹× µ¿Çâ

Grand View Research, IncÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀåÀº 2030³â±îÁö 22¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024-2030³â CAGR 5.53%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±â¼úÀÇ Áøº¸·Î ½ÊÀÌÁöÀå ³»½Ã°æÀº ¶Ù¾î³­ À̹Ì¡ ´É·Â, Çâ»óµÈ Á¶ÀÛ¼º, ÃÖ÷´Ü Áø´Ü µµ±¸¿ÍÀÇ ÅëÇÕÀ» Á¦°øÇÏ¿© Áø´Ü ¹× Ä¡·á ¿ëµµ ºÐ¾ß¿¡¼­ È¿´ÉÀ» ³ôÀÔ´Ï´Ù. °Ô´Ù°¡ À§Àå ÁúȯÀÇ À¯º´·üÀÇ »ó½ÂÀº ³»½Ã°æ óġÀÇ ¼ö¿ä¸¦ È®´ë½ÃÄÑ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ ¾ÈÀü¼º°ú °¨¿° Á¦¾î¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µÇ´Â ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Àúħ½À ¼ö¼ú·ÎÀÇ ÀüȯÀº Àǻ簡 ´õ ÀÛÀº Àý°³, ´õ ÀûÀº Á¶Á÷ ¼Õ»ó, ´õ ºü¸¥ ȯÀÚÀÇ È¸º¹ ½Ã°£À» Æ÷ÇÔÇÏ´Â ±â¼úÀ» »ç¿ëÇÏ´Â °ÍÀ» ¼±È£ÇÏ´Â Çö´ë ÀÇ·áÀÇ ±¤¹üÀ§ÇÑ °æÇâÀ» ÀǹÌÇÕ´Ï´Ù. ħ½ÀÀÌ Å©°í Àå±âÀÔ¿øÀ» ÇÊ¿ä·Î ÇÏ´Â ±âÁ¸Çü °³º¹¼ö¼ú ´ë½Å Àúħ½À ¼ö¼ú·Î´Â Ä¡À¯°¡ ºü¸£°í ÇÕº´ÁõÀÌ ÀûÀ¸¸ç ÅëÁõµµ Àû½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ÀÌ·¯ÇÑ ÀåºñÀÇ È¿´É°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½ÃŰ´Â ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÁÖ·Î ERCP ¼Õ±â¼ú¿¡ »ç¿ëµÇ´Â ½ÊÀÌÁöÀå ³»½Ã°æÀº °íÁ¤¹Ð ¿µ»ó, À¯¿¬¼º Çâ»ó, Á¦¾î °³¼±À» Ư¡À¸·Î Çϸç, ´õ ³ªÀº ÀÌ»ó °ËÃâ°ú ´õ ¾ÈÀüÇÑ ¼Õ±â¼úÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀϺΠ±âÁ¾¿¡´Â ½Ç½Ã°£ À̹ÌÁö ºÐ¼®°ú ³»ºñ°ÔÀ̼ÇÀ» À§ÇÑ AI ±â´ÉÀÌ Å¾ÀçµÅ º¸´Ù ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´ÜÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº, º´¿øÀ̳ª Ŭ¸®´Ð¿¡ ½Å±âÁ¾¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÀçÃËÇØ, ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

³»½Ã°æÀû ÃÊÀ½ÆÄ °Ë»ç(EUS)³ª ³»½Ã°æÀû ¿ªÇ༺ ´ã°ü Ãé°ü Á¶¿µ(ERCP) µîÀÇ ³»½Ã°æ °Ë»ç´Â ¼ÒÈ­°üÀ̳ª Æó µîÀÇ ¾ÏÀ» °ËÃâ ¹× Æò°¡ÇÏ´Â µ¥ À¯¿ëÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Õ±â¼ú¿¡ ÀÇÇØ °³º¹ ¼ö¼úÀ» ÇÏÁö ¾Ê°í ³»ºÎ Á¶Á÷ÀÇ Á¤È®ÇÑ °¡½ÃÈ­, »ý°Ë äÃë, ³ª¾Æ°¡ Àü¾Ï Áõ½ÄÀ̳ª Á¶±â Á¾¾çÀÇ ÀýÁ¦°¡ °¡´ÉÇØÁý´Ï´Ù. À̸¦ ÅëÇØ ȯÀÚÀÇ ¿¹Èİ¡ °³¼±µÇ°í ȸº¹¿¡ ¼Ò¿äµÇ´Â ½Ã°£ÀÌ Å©°Ô ´ÜÃàµÇ¸ç ħ½ÀÀûÀÎ ¿Ü°ú ¼ö¼ú¿¡ µû¸¥ ÇÕº´ÁõÀÇ À§Çèµµ ÁÙ¾îµì´Ï´Ù.

¶ÇÇÑ, °íÇØ»óµµ ½Ã°¢È­ ¹× Áø´Ü °­È­¸¦ À§ÇÑ ÀΰøÁö´É(AI)ÀÇ ÅëÇÕÀ» Æ÷ÇÔÇÑ ³»½Ã°æ ±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ ÀÌ·¯ÇÑ Ä¡·á´Â ¾ÏÀÇ Á¶±â ´Ü°è¿¡¼­ÀÇ ¹ß°ß°ú Ä¡·á¿¡ ´õ¿í È¿°úÀûÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¦Ç°º°·Î´Â Àç»ç¿ë °¡´É ºÎ¹®ÀÌ 2024³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â ¼±ÁøÀû ¼ÒÈ­°ü ³»½Ã°æ óġ, ƯÈ÷ ³»½Ã°æÀû ¿ªÇ༺ ´ã°üÃé°üÁ¶¿µ(ERCP)ÀÇ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.
  • Ä¡·á ¹× ó¸® ºÎ¹®Àº 2024³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â ÇコÄÉ¾î °ø±ÞÀÚµéÀÌ È¸º¹ ½Ã°£ ´ÜÃà µî °ü·Ã ÀåÁ¡À¸·Î ÀÎÇØ Àúħ½À ±â¼úÀ» Á¡Á¡ ¼±È£ÇÏ°Ô µÈ µ¥ ±âÀÎÇϰí ÀÖ½À´Ï´Ù.
  • ¿Ü·¡ ȯÀÚ ½Ã¼³ ºÎ¹®Àº ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó 2024³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. À̰ÍÀº, ÀÇ·á ±â¼úÀÇ Áøº¸°¡ ÁøÇàµÇ°í ÀÖ´Â °Í°ú Àúħ½À¼º ¼Õ±â¼ú¿¡ ´ëÇÑ È¯ÀÚÀÇ ±âÈ£°¡ º¯È­Çϰí ÀÖ´Â °Í¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù.
  • ÀÌ ½ÃÀåÀÇ À¯·Â ±â¾÷¿¡´Â Ambu A/S, Olympus Corporation, Boston Scientific Corporation, PENTAX Medical(Hoya Corporation), FUJIFILM Holdings Corporation, Ottomed Endoscopy, SonoScape Medical Corp. µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ ¹× ¹üÀ§

  • ½ÃÀå °èÅëÀÇ Àü¸Á
    • ¸ð ½ÃÀå Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ½ÊÀÌÁöÀå ³»½Ã°æ : ½ÃÀå ºÐ¼® µµ±¸
    • »ê¾÷ ºÐ¼®-Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼ú
  • ÀÌ¿ë »ç·Ê ºÐ¼®
  • ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : óġ·® ÃßÁ¤(2018-2023³â)(1,000°³)

Á¦4Àå ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå ºÎ¹® ºÐ¼® : Á¦Ç°º°(2018-2030³â)

  • Á¤ÀÇ ¹× ¹üÀ§
  • Á¦Ç°º° ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â, 2030³â)
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : Á¦Ç°º°(2018-2030³â)
  • Àç»ç¿ë °¡´É
    • ÀçÀÌ¿ë °¡´É ½ÃÀå ¼öÀÍ ÃßÁ¤ ¹× ¿¹Ãø(2018-2030³â)
    • ¿¬Áú
    • °æÁú
  • ÀÏȸ¿ë
    • ÀÏȸ¿ë ½ÃÀå ¼öÀÍ ÃßÁ¤ ¹× ¿¹Ãø(2018-2030³â)

Á¦5Àå ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå ºÎ¹® ºÐ¼® : ¿ëµµº°(2018-2030³â)

  • Á¤ÀÇ ¹× ¹üÀ§
  • ¿ëµµº° ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â, 2030³â)
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : ¿ëµµº°(2018-2030³â)
  • Áø´Ü
    • Áø´Ü ½ÃÀå ¼öÀÍ ÃßÁ¤ ¹× ¿¹Ãø(2018-2030³â)
  • Ä¡·á ¹× óġ
    • Ä¡·á ¹× óġ ½ÃÀå ¼öÀÍ ÃßÁ¤ ¹× ¿¹Ãø(2018-2030³â)

Á¦6Àå ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå ºÎ¹® ºÐ¼® : ÃÖÁ¾ ¿ëµµº°(2018-2030³â)

  • Á¤ÀÇ ¹× ¹üÀ§
  • ÃÖÁ¾ ¿ëµµº° ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â, 2030³â)
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°(2018-2030³â)
  • º´¿ø
    • º´¿ø ½ÃÀå ¼öÀÍ ÃßÁ¤ ¹× ¿¹Ãø(2018-2030³â)
  • ¿Ü·¡½Ã¼³
    • ¿Ü·¡ ½Ã¼³ ½ÃÀå ¼öÀÍ ÃßÁ¤ ¹× ¿¹Ãø(2018-2030³â)

Á¦7Àå ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå ºÎ¹® ºÐ¼® : Áö¿ªº°(2018-2030³â)

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â, 2030³â)
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • Áö¿ªº° ½ÃÀå ÇöȲ
  • ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå Á¡À¯À² : Áö¿ªº°(2024³â, 2030³â)
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • ½º¿þµ§
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ ¹× ¿µÇ⠺м®
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´× ºÐ¼®
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ambu A/S
    • Olympus Corporation
    • Boston Scientific Corporation
    • PENTAX Medical(Hoya Corporation)
    • FUJIFILM Holdings Corporation
    • Ottomed Endoscopy
    • SonoScape Medical Corp.
AJY 25.05.29

Duodenoscopes Market Size & Trends:

The global duodenoscopes market is anticipated to reach USD 2.20 billion by 2030 and is anticipated to expand at a CAGR of 5.53% from 2024 to 2030, according to a new report by Grand View Research, Inc. Advances in technology have resulted in duodenoscopes that offer better imaging capabilities, enhanced maneuverability, and integration with cutting-edge diagnostic tools, which increases their effectiveness in both diagnostic and therapeutic applications. Moreover, the rising prevalence of gastrointestinal disorders has escalated the demand for endoscopic procedures, driving market growth further. A growing focus on patient safety and infection control has led to a rise in single-use duodenoscopes, which help reduce the risk of cross-contamination.

The shift towards minimally invasive procedures refers to a broader trend in modern medicine where doctors prefer using techniques involving smaller incisions, less tissue damage, and quicker patient recovery times. Instead of traditional open surgeries, which are more invasive and require more extended hospital stays, minimally invasive methods allow for faster healing, fewer complications, and less pain.

The market is growing due to technological advancements that enhance the effectiveness and user-friendliness of these devices. Duodenoscopes, used mainly for ERCP procedures, feature high-definition imaging, improved flexibility, and control, allowing for better detection of abnormalities and safer procedures. Some models now include AI features for real-time image analysis and navigation, leading to quicker and more accurate diagnoses. These innovations are prompting hospitals and clinics to invest in newer models, driving market growth.

Endoscopic procedures, such as Endoscopic Ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP), are valuable in detecting & assessing cancer in the gastrointestinal tract, lung, and other areas. These procedures allow for precise visualization of internal tissues, biopsy collection, and even the removal of precancerous growths or early-stage tumors without open surgery. This improves patient outcomes and significantly reduces recovery times & the risk of complications associated with invasive surgical procedures.

Moreover, advancements in endoscopic technologies, including high-definition visualization and the integration of artificial intelligence (AI) for enhanced diagnosis, are making these procedures even more effective at detecting and treating cancer at its early stages.

Duodenoscopes Market Report Highlights:

  • Based on product, the reusable segment held the largest market share in 2024. This is attributed to the increasing demand for advanced gastrointestinal endoscopic procedures, particularly endoscopic retrograde cholangiopancreatography (ERCP)
  • The therapeutics/ treatment segment held the largest market share in 2024 based on application. This can be attributed to healthcare providers increasingly preferring minimally invasive techniques due to their associated benefits, such as reduced recovery times
  • The outpatient facilities segment held the largest market share in 2024 based on end use. This can be attributed to increasing advancements in medical technology and changing patient preferences towards less invasive procedures
  • Some prominent players in the market include Ambu A/S, Olympus Corporation, Boston Scientific Corporation, PENTAX Medical (Hoya Corporation), FUJIFILM Holdings Corporation, Ottomed Endoscopy, and SonoScape Medical Corp.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Duodenoscopes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Duodenoscopes: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Landscape
  • 3.5. Technology Landscape
  • 3.6. Case Study Analysis
  • 3.7. Duodenoscopes Market, Procedure Volume Estimates, 2018 - 2023 (000' Units)

Chapter 4. Duodenoscopes Market Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Duodenoscopes Market, by Product, 2018 to 2030
  • 4.5. Reusable
    • 4.5.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Flexile
      • 4.5.2.1. Flexile Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Rigid
      • 4.5.3.1. Rigid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Disposable
    • 4.6.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Duodenoscopes Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Duodenoscopes Market, by Application, 2018 to 2030
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Therapeutics/ Treatment
    • 5.6.1. Therapeutics/ Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Duodenoscopes Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Duodenoscopes Market, by End Use, 2018 to 2030
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Outpatient Facilities
    • 6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Duodenoscopes Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Duodenoscopes Market Share by Region, 2024 & 2030:
  • 7.5. North America
    • 7.5.1. North America duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico duodenoscopes market, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Regulatory Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Regulatory Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark duodenoscopes market, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Regulatory Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Regulatory Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand duodenoscopes market, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina duodenoscopes market, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key Country Dynamics
      • 7.9.1.2. Regulatory Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE duodenoscopes market, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait duodenoscopes market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Market Position Analysis
  • 8.3. Company Profiles
    • 8.3.1. Ambu A/S
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Platform benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Olympus Corporation
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Platform benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Boston Scientific Corporation
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Platform benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. PENTAX Medical (Hoya Corporation)
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Platform benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. FUJIFILM Holdings Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Platform benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Ottomed Endoscopy
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Platform benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. SonoScape Medical Corp.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Platform benchmarking
      • 8.3.7.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦